Defective regulation of MicroRNA target genes in myoblasts from facioscapulohumeral dystrophy patients

Journal of Biological Chemistry

Volumn 288, Issue 49, 2013, Pages 34989-35002

  Dmitriev, Petr ^a,b   Stankevicins, Luiza ^a   Ansseau, Eugenie ^f   Petrov, Andrei ^e   Barat, Ana ^a   Dessen, Philippe ^c   Robert, Thomas ^c   Turki, Ahmed ^b   Lazar, Vladimir ^c   Labourer, Emmanuel ^d   Belayew, Alexandra ^f   Carnac, Gilles ^b   Laoudj Chenivesse, Dalila ^b   Lipinski, Marc ^a   Vassetzky, Yegor S ^a  

^a UMR 8126   (France)

^b UNIVERSITY OF MONTPELLIER   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d APPLIED BIOSYSTEMS   (United States)

^e University of Mons ^*  (Russian Federation)

^f UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEOBOX GENES; MICRORNAS; MIRNA EXPRESSIONS; MYOBLASTS; OVER-EXPRESSION; TARGET GENES;

GENES;

RNA;

MESSENGER RNA; MICRORNA 1; MICRORNA 100; MICRORNA 107; MICRORNA 133A; MICRORNA 133B; MICRORNA 139; MICRORNA 152; MICRORNA 15A; MICRORNA 15B; MICRORNA 206; MICRORNA 20B; MICRORNA 21B; MICRORNA 22; MICRORNA 223; MICRORNA 25; MICRORNA 302B; MICRORNA 30E; MICRORNA 32; MICRORNA 331; MICRORNA 362; MICRORNA 365; MICRORNA 382; MICRORNA 496; MICRORNA 532; MICRORNA 654; MICRORNA 660; MICRORNA 7; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DUX4 GENE; DUX4C GENE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE TARGETING; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; MYOBLAST; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION; YOUNG ADULT;

FACIOSCAPULOHUMERAL DYSTROPHY; GENETIC DISEASES; MICRORNA; MUSCULAR DYSTROPHY; TRANSCRIPTION; TRANSCRIPTION REGULATION;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS, SKELETAL; UP-REGULATION; YOUNG ADULT;

EID: 84890277215     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.504522     Document Type: Article

References (66)

1. Tawil, R. (2008) Facioscapulohumeral muscular dystrophy. Neurotherapeutics 5, 601-606
2. Wijmenga, C., Hewitt, J. E., Sandkuijl, L. A., Clark, L. N., Wright, T. J., Dauwerse, H. G., Gruter, A. M., Hofker, M. H., Moerer, P., and Williamson, R. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2, 26-30
3. van Deutekom, J. C., Wijmenga, C., van Tienhoven, E. A., Gruter, A. M., Hewitt, J. E., Padberg, G. W., van Ommen, G. J., Hofker, M. H., and Frants, R. R. (1993) FSHD associatedDNArearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037-2042
4. van Geel, M., Heather, L. J., Lyle, R., Hewitt, J. E., Frants, R. R., and de Jong, P. J. (1999) The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements. Genomics 61, 55-65
5. Gabriels, J., Beckers, M. C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S. M., Padberg, G. W., Frants, R. R., Hewitt, J. E., Collen, D., and Belayew, A. (1999) Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236, 25-32
6. Dmitriev, P., Lipinski, M., and Vassetzky, Y. S. (2009) Pearls in the junk. Dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 19, 17-20
7. Snider, L., Geng, L. N., Lemmers, R. J., Kyba, M., Ware, C. B., Nelson, A. M., Tawil, R., Filippova, G. N., van der Maarel, S. M., Tapscott, S. J., and Miller, D. G. (2010) Facioscapulohumeral dystrophy. Incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181
8. Lemmers, R. J., van der Vliet, P. J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J. G., Snider, L., Straasheijm, K. R., van Ommen, G. J., Padberg, G. W., Miller, D. G., Tapscott, S. J., Tawil, R., Frants, R. R., and van der Maarel, S. M. (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653
9. Tsumagari, K., Chang, S. C., Lacey, M., Baribault, C., Chittur, S. V., Sowden, J., Tawil, R., Crawford, G. E., and Ehrlich, M. (2011) Gene expression during normal and FSHD myogenesis. BMC Med. Genomics 4, 67
10. Bakay, M., Wang, Z., Melcon, G., Schiltz, L., Xuan, J., Zhao, P., Sartorelli, V., Seo, J., Pegoraro, E., Angelini, C., Shneiderman, B., Escolar, D., Chen, Y. W., Winokur, S. T., Pachman, L. M., Fan, C., Mandler, R., Nevo, Y., Gordon, E., Zhu, Y., Dong, Y., Wang, Y., and Hoffman, E. P. (2006) Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 129, 996-1013
11. Celegato, B., Capitanio, D., Pescatori, M., Romualdi, C., Pacchioni, B., Cagnin, S., Viganò, A., Colantoni, L., Begum, S., Ricci, E., Wait, R., Lanfranchi, G., and Gelfi, C. (2006) Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6, 5303-5321
12. van Overveld, P. G., Lemmers, R. J., Sandkuijl, L. A., Enthoven, L., Winokur, S. T., Bakels, F., Padberg, G. W., van Ommen, G. J., Frants, R. R., and van der Maarel, S. M. (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35, 315-317
13. Winokur, S. T., Chen, Y. W., Masny, P. S., Martin, J. H., Ehmsen, J. T., Tapscott, S. J., van der Maarel, S. M., Hayashi, Y., and Flanigan, K. M. (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12, 2895-2907
14. Laoudj-Chenivesse, D., Carnac, G., Bisbal, C., Hugon, G., Bouillot, S., Desnuelle, C., Vassetzky, Y., and Fernandez, A. (2005) Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med. 83, 216-224
15. Winokur, S. T., Barrett, K., Martin, J. H., Forrester, J. R., Simon, M., Tawil, R., Chung, S. A., Masny, P. S., and Figlewicz, D. A. (2003) Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 13, 322-333
16. Osborne, R. J., Welle, S., Venance, S. L., Thornton, C. A., and Tawil, R. (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68, 569-577
17. Cheli, S., François, S., Bodega, B., Ferrari, F., Tenedini, E., Roncaglia, E., Ferrari, S., Ginelli, E., and Meneveri, R. (2011) Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One 6, e20966
18. Bosnakovski, D., Lamb, S., Simsek, T., Xu, Z., Belayew, A., Perlingeiro, R., and Kyba, M. (2008) DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp. Neurol. 214, 87-96
19. Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R. R., and Kyba, M. (2008) An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 27, 2766-2779
20. Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S. D., Coppée, F., and Belayew, A. (2011) The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 6, e26820
21. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M. A., Bottinelli, R., Green, M. R., and Tupler, R. (2006) Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973-977
22. Petrov, A., Pirozhkova, I., Carnac, G., Laoudj, D., Lipinski, M., and Vassetzky, Y. S. (2006) Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc. Natl. Acad. Sci. U.S.A. 103, 6982-6987
23. Pirozhkova, I., Petrov, A., Dmitriev, P., Laoudj, D., Lipinski, M., and Vassetzky, Y. (2008) A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One 3, e3389
24. Bodega, B., Ramirez, G. D., Grasser, F., Cheli, S., Brunelli, S., Mora, M., Meneveri, R., Marozzi, A., Mueller, S., Battaglioli, E., and Ginelli, E. (2009) Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol. 7, 41
25. Petrov, A., Laoudj, D., and Vasetski, E. (2003) [Genetics and epigenetics of facio-scapulohumeral progressive (Landouzy-Dejerine) muscular dystrophy]. Genetika 39, 202-206
26. Petrov, A., Allinne, J., Pirozhkova, I., Laoudj, D., Lipinski, M., and Vassetzky, Y. S. (2008) A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo. Implications for the facio-scapulohumeral dystrophy. Genome Res. 18, 39-45
27. Dmitriev, P., Petrov, A., Ansseau, E., Stankevicins, L., Charron, S., Kim, E., Bos, T. J., Robert, T., Turki, A., Coppée, F., Belayew, A., Lazar, V., Carnac, G., Laoudj, D., Lipinski, M., and Vassetzky, Y. S. (2011) The Kruppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy. J. Biol. Chem. 286, 44620-446231
28. Cabianca, D. S., Casa, V., Bodega, B., Xynos, A., Ginelli, E., Tanaka, Y., and Gabellini, D. (2012) A long ncRNA links copy number variation to a polycomb/ trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149, 819-831
29. Vizoso, M., and Esteller, M. (2012) The activatory long non-coding RNA DBE-T reveals the epigenetic etiology of facioscapulohumeral muscular dystrophy. Cell Res. 22, 1413-1415
30. Block, G. J., Petek, L. M., Narayanan, D., Amell, A. M., Moore, J. M., Rabaia, N. A., Tyler, A., van der Maarel, S. M., Tawil, R., Filippova, G. N., and Miller, D. G. (2012) Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production. PLoS One 7, e35532
31. Eisenberg, I., Eran, A., Nishino, I., Moggio, M., Lamperti, C., Amato, A. A., Lidov, H. G., Kang, P. B., North, K. N., Mitrani-Rosenbaum, S., Flanigan, K. M., Neely, L. A., Whitney, D., Beggs, A. H., Kohane, I. S., and Kunkel, L. M. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. U.S.A. 104, 17016-17021
32. Barro, M., Carnac, G., Flavier, S., Mercier, J., Vassetzky, Y., and Laoudj- Chenivesse, D. (2010) Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J. Cell Mol. Med. 14, 275-289
33. Zhu, C. H., Mouly, V., Cooper, R. N., Mamchaoui, K., Bigot, A., Shay, J. W., Di Santo, J. P., Butler-Browne, G. S., and Wright, W. E. (2007) Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase Consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6, 515-523
34. Zhao, Y., Samal, E., and Srivastava, D. (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220
35. Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M. L., Segnalini, P., Gu, Y., Dalton, N. D., Elia, L., Latronico, M. V., Høydal, M., Autore, C., Russo, M. A., Dorn, G. W., 2nd, Ellingsen, O., Ruiz-Lozano, P., Peterson, K. L., Croce, C. M., Peschle, C., and Condorelli, G. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613-618
36. Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., and Coppée, F. (2009) DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One 4, e7482
37. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A. M., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., and Chen, Y. W. (2007) DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. U.S.A. 104, 18157-18162
38. Chomczynski, P., and Sacchi, N. (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 1, 581-585
39. Smyth, G. K. (2005) Limma. Linear models for microarray data. in Bioinformatics and Computational Biology Solutions Using R and Bioconductor (Gentleman, R., Carey, V., Dudoit, S., and Hubert, W., eds) pp. 397-420, Springer, New York
40. Harafuji, N., Schneiderat, P., Walter, M. C., and Chen, Y. W. (2013) miR- 411 is up-regulated in FSHD myoblasts and suppresses myogenic factors. Orphanet J. Rare Dis. 8, 55
41. Ge, Y., and Chen, J. (2011) MicroRNAs in skeletal myogenesis. Cell Cycle 10, 441-448
42. Hiti, A. L., Bogenmann, E., Gonzales, F., and Jones, P. A. (1989) Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol. Cell. Biol. 9, 4722-4730
43. Tapscott, S. J., Thayer, M. J., and Weintraub, H. (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453
44. Bartel, D. P. (2004) MicroRNAs. Genomics, biogenesis, mechanism, and function. Cell 116, 281-297
45. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., and Johnson, J. M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773
46. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840
47. Miranda, K. C., Huynh, T., Tay, Y., Ang, Y. S., Tam, W. L., Thomson, A. M., Lim, B., and Rigoutsos, I. (2006) A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217
48. Lemmers, R. J., Wohlgemuth, M., van der Gaag, K. J., van der Vliet, P. J., van Teijlingen, C. M., de Knijff, P., Padberg, G. W., Frants, R. R., and van der Maarel, S. M. (2007) Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 884-894
49. Lemmers, R. J., van der Vliet, P. J., van der Gaag, K. J., Zuniga, S., Frants, R. R., de Knijff, P., and van der Maarel, S. M. (2010) Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am. J. Hum. Genet. 86, 364-377
50. Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E., and Bozzoni, I. (2011) miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 3, 258-265
51. Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S., and Lodish, H. F. (2006) Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. U.S.A. 103, 8721-8726
52. Tupler, R., Berardinelli, A., Barbierato, L., Frants, R., Hewitt, J. E., Lanzi, G., Maraschio, P., and Tiepolo, L. (1996) Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet. 33, 366-370
53. Deak, K. L., Lemmers, R. J., Stajich, J. M., Klooster, R., Tawil, R., Frants, R. R., Speer, M. C., van der Maarel, S. M., and Gilbert, J. R. (2007) Genotype- phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology 68, 578-582
54. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., and Wang, D. Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233
55. McCarthy, J. J., Esser, K. A., and Andrade, F. H. (2007) MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am. J. Physiol. Cell Physiol. 293, C451-C457
56. Ameres, S. L., and Zamore, P. D. (2013) Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol. 14, 475-488
57. Geng, L. N., Yao, Z., Snider, L., Fong, A. P., Cech, J. N., Young, J. M., van der Maarel, S. M., Ruzzo, W. L., Gentleman, R. C., Tawil, R., and Tapscott, S. J. (2012) DUX4 activates germline genes, retroelements, and immune mediators. Implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38-51
58. Sharma, V., Harafuji, N., Belayew, A., and Chen, Y. W. (2013) DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One 8, e64691
59. Mukherji, S., Ebert, M. S., Zheng, G. X., Tsang, J. S., Sharp, P. A., and van Oudenaarden, A. (2011) MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 43, 854-859
60. Chien, C. H., Sun, Y. M., Chang, W. C., Chiang-Hsieh, P. Y., Lee, T. Y., Tsai, W. C., Horng, J. T., Tsou, A. P., and Huang, H. D. (2011) Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 39, 9345-9356
61. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., Tramontano, A., and Bozzoni, I. (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369
62. Corcoran, D. L., Pandit, K. V., Gordon, B., Bhattacharjee, A., Kaminski, N., and Benos, P. V. (2009) Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 4, e5279
63. Fujita, S., and Iba, H. (2008) Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics 24, 303-308
64. Ciarapica, R., Russo, G., Verginelli, F., Raimondi, L., Donfrancesco, A., Rota, R., and Giordano, A. (2009) Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 8, 172-175
65. Granjon, A., Gustin, M. P., Rieusset, J., Lefai, E., Meugnier, E., Guller, I., Cerutti, C., Paultre, C., Disse, E., Rabasa-Lhoret, R., Laville, M., Vidal, H., and Rome, S. (2009) The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein- 1c/myocyte enhancer factor 2C pathway. Diabetes 58, 2555-2564
66. Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., and Ambros, V. (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5, R13